Genetic and Molecular Mechanisms Driving Antifungal Resistance in Emerging Fungal Species

Fungal infections have now become a significant threat to a broader range of patients worldwide. Factors such as increased use of immunosuppressive treatments, invasive medical procedures, widespread antibiotic use, and ageing populations have driven a surge in invasive fungal infections, which cause millions of deaths each year—surpassing fatalities from diseases like tuberculosis and malaria. This chapter explores the shifting landscape of fungal diseases, marked by the rise of new fungal pathogens and the alarming spread of multidrug resistance in species such as Candida auris, Candida glabrata, Aspergillus fumigatus, and Cryptococcus neoformans. Resistance to antifungal drugs is complex, arising from natural resistance traits, genetic mutations acquired under drug pressure, and clinical factors that reduce treatment effectiveness. These mechanisms involve sophisticated genetic and epigenetic changes, enhanced drug efflux, biofilm formation, and alterations in fungal morphology, which together make treatment increasingly difficult. Environmental factors, such as the use of agricultural fungicides, further complicate the issue by promoting resistance in fungi like A. fumigatus. Tackling this growing threat requires a coordinated approach that integrates scientific advances, clinical practice, and policy initiatives to prevent fungal infections from becoming an even greater global health crisis.